Announcements Trials
Browse Landscape

Phase

Phase 4 3Phase 2 1

Status

Completed 18Terminated 4

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Thoracic 1

Conditions

Pleural Effusion, Malignant 1Pain 1Emergencies 1Cancer Pain 1Breakthrough Pain 1Bone Metastases 1

Interventions

Cyclophosphamide 222pembrolizumab 201Carboplatin 173Cisplatin 168Gemcitabine 167Paclitaxel 155Docetaxel 140Bevacizumab 138Rituximab 137Radiotherapy 137Nivolumab 126Dexamethasone 126Capecitabine 103fludarabine 102Pemetrexed 92fludarabine phosphate 91Fluorouracil 91Doxorubicin 85Oxaliplatin 79Etoposide 77Cytarabine 77Bortezomib 76Erlotinib Hydrochloride 74Leucovorin 72Filgrastim 68Lenalidomide 67Calcium Dobesilate 66Irinotecan 65atezolizumab 63Radiation 61

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Terminated × Has results × Fentanyl × Clear all
NCT01812759 2021-06-29

Fentanyl for Breakthrough Pain in the Emergency Department

M.D. Anderson Cancer Center

Phase 4 Terminated
3 enrolled 8 charts

Emergencies, Pain

NCT03071744 2019-12-09

Lazanda in Cancer Patients Receiving Palliative Radiation

University of California, San Diego

Phase 2 Terminated
6 enrolled 10 charts

Bone Metastases

NCT02623959 2019-08-07

Indwelling Pleural Catheter With Either Doxycycline or Saline at Day 7 for Pleurodesis

M.D. Anderson Cancer Center

Phase 4 Terminated
3 enrolled 4 charts
Thoracic

Pleural Effusion, Malignant

NCT00842829 2012-10-01

Study of Breakthrough Cancer Pain: Assessment of Fentanyl Buccal Tablets Titration and Treatment in Opioid-Tolerant Patients

Teva Branded Pharmaceutical Products R&D, Inc.

Phase 4 Terminated
330 enrolled 32 charts

Cancer Pain, Breakthrough Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡